The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination

• Published in: PloS one 2015-10, Vol.10 (10), p.e0139730-e0139730
• Main Authors: Huang, Jean, Ou, Horng-Yih, Lin, James, Karnchanasorn, Rudruidee, Feng, Wei, Samoa, Raynald, Chuang, Lee-Ming, Chiu, Ken C
• Format: Article
• Language: English
• Subjects: Alcohol use; Alcoholic beverages; Body mass; Care and treatment; Confidence Intervals; Demography; Diabetes; Diabetes mellitus; Diabetes Mellitus - immunology; Disease prevention; Dosage and administration; Endocrinology; Female; Genetics; Glucose; Health care; Health risks; Hemoglobin; Hepatitis; Hepatitis B; Hepatitis B - blood; Hepatitis B - immunology; Hepatitis B vaccines; Hepatitis B Vaccines - immunology; Hepatitis C; Humans; Immunization; Infections; Insulin resistance; Internal medicine; Intervention; Lifestyles; Liver; Liver diseases; Male; Metabolism; Middle Aged; Nutrition; Odds Ratio; Poverty; Preventive medicine; Public health; Risk; Risk Factors; Risk Reduction Behavior; Serology; Studies; Vaccination; Viruses
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0139730

The liver plays a key role in fuel metabolism. It is well established that liver disease is associated with an increased risk for diabetes mellitus. Hepatitis C virus infection has been known to increase the risk of diabetes. However, much less is known about the role of hepatitis B virus (HBV) infection in diabetes. We examined the association of diabetes based on the vaccination status for HBV. In this cross-sectional study, we included adult subjects (≥20 y/o) with HBV serology available from the National Health and Nutrition Examination Survey 2005-2010. Diabetes was defined as established diabetes or fasting plasma glucose concentration ≥7.0 mmol/L, 2-hour plasma glucose concentration ≥11.1 mmol/L, or HbA1c ≥ 47.5 mmol/mol (6.5%). Vaccination was based on the reported history and immunization was determined by HBV serology. The odds ratio (OR) with 95% confidence intervals (95% CI) were calculated with consideration of the following covariates: age, gender, BMI, ethnic/racial group, current smoker, current alcohol consumption, family history of diabetes, poverty index, and education. This study included 15,316 subjects. Among them, 2,320 subjects was immunized based the HBV serology. Among 4,063 subjects who received HBV vaccination, successful vaccination was only noted in 39% of subjects. The HBV vaccination was not associated with diabetes (OR: 1.08, 95%CI: 0.96-1.23). Serology evidence of HBV immunization was associated with a reduced OR of diabetes (0.75, 95%CI: 0.62-0.90). Successful HBV vaccination was also associated with a reduced OR of diabetes (0.67, 95%CI: 0.52-0.84). Although our study shows the association of HBV vaccination with the reduced odds of diabetes by 33%, a prospective study is warranted to confirm and examine the impact of HBV vaccination in prevention of diabetes.